Science

Linda A. Parker explains the mood enhancing and anti-depressant qualities of CBD and THC.

Oxford University, the oldest university in England, will be at the forefront of a new global center of excellence set up to carry out a £10 million dollar research program to study cannabis. The initial investment, which equates to about $12.36 million US, is being...

By Adrian Devitt-Lee on September 08, 2015 With cannabidiol (CBD) poised to become widely available in pharmaceutical, nutraceutical, and herbal preparations, medical scientists are taking a closer look at CBD-drug interactions. Read full article...

New research discusses the roles of CB1 and CB2 cannabinoid receptors pertaining to diet, digestion, and energy metabolism.

Because it is considered a Schedule 1 drug by the federal government, conducting a randomized controlled trial on marijuana use is essentially impossible. Read Full Article at: Cannabist Why are there so many conflicting marijuana studies?

By Martin A. Lee on February 09, 2017 Originally published in High Times (Feb. 2017) “This changes everything!” That was the immediate reaction of Bay Area journalist Fred Gardner as he stood in the office of Steep Hill Laboratory in Oakland and eyed a chromatogram...

A cutting edge paper from three cannabis friendly medical professionals— Dustin Sulak, Russel Saneto, and Bonni Goldstein— outlines case reports and the applications of cannabis medicine for epilepsy and seizure disorders. Cannabis clinicians treating epileptic...

CBD can be the perfect entryway for those who are unfamiliar with cannabis.

There’s certainly a major trend toward CBD-only products on the cannabis market.

According to a recent Washington Post/Kaiser Family Foundation survey, 1 in 3 long-term prescription painkiller users report being addicted or dependent, and abuse of opioid medications may actually open the door to heroin use. Is there a better way to treat chronic...